These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Metoprolol in hypertension: an open evaluation.
    Author: Assaykeen TA, Michell G.
    Journal: Med J Aust; 1982 Jan 23; 1(2):73-7. PubMed ID: 7040924.
    Abstract:
    We studied the efficacy and tolerability of metoprolol, administered alone or in combination therapy, in 703 hypertensive patients. We observed a significant decrease in both systolic and diastolic blood pressure in patients treated with metoprolol alone or with metoprolol and a diuretic. Of these, 60% to 85% achieved a diastolic blood pressure of 12 kPa (90 mmHg) or lower during the 12-week trial. The maximum effect occurred after approximately three weeks. In the majority of patients, 100 mg twice a day controlled mild to moderate hypertension. Side effects (mainly gastrointestinal disturbances and dizziness) occurred in 15% of patients receiving metoprolol alone and led to treatment withdrawal in 6.7%. For the total patients population, these frequencies were 13.5% and 6.7% respectively, and decreased with time. Asthmatics and diabetics tolerated metoprolol extremely well, indicating the clinical importance of metoprolol's cardioselectivity.
    [Abstract] [Full Text] [Related] [New Search]